Company intelligence / Profile preview

Confocal

Amsterdam, Netherlands

Ownership: Private
Development stage: Other

Overview

Confocal NL manufactures REscan Confocal Microscopy (RCM) systems that achieve 170 nm resolution with 40% improved resolution compared to standard confocal microscopes, combined with four times higher signal-to-noise ratio. When combined with deconvolution, resolution improves to 120 nm. The technology uses sensitive cameras with 95% quantum efficiency in the visible range versus 45% for traditional photomultiplier tubes.

Modalities: Device
Industry: Pathology

Beyond the preview

Go deeper on Confocal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Confocal.

Explore the full profile